Premium
Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?
Author(s) -
Harvey Ken J,
Day Richard O,
Campbell William G,
Lipworth Wendy
Publication year - 2011
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2011.tb03105.x
Subject(s) - ophthalmology , library science , medicine , macular degeneration , art , computer science
The cost differential between these two drugs is no longer defensible.